Doello, KevinAmezcua, Víctor2023-02-092023-02-092021-05-07http://hdl.handle.net/10668/17949enCOVID-19CefepimeHeparin, Low-Molecular-WeightHumansNeoplasmsSARS-CoV-2Effect of adding bemiparin and cefepime to routine treatment in cancer patients with SARS-CoV-2 infection.Efecto de la adición de bemiparina y cefepime al tratamiento habitual en el paciente oncológico con infección por SARS-CoV-2.research article34083071open access10.1016/j.medcli.2021.03.0101578-8989PMC8103150https://doi.org/10.1016/j.medcli.2021.03.010https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103150/pdf